We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
-28.09%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$149M
(+25%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
61.59%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,737
New
568
Increased
434
Reduced
241
Closed
491
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$11.5M |
| 2 |
Nucor
NUE
|
+$9.58M |
| 3 |
Microsoft
MSFT
|
+$9.57M |
| 4 |
Duke Energy
DUK
|
+$9.38M |
| 5 |
Costco
COST
|
+$7.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$10M |
| 2 |
FirstEnergy
FE
|
+$7.33M |
| 3 |
Exelon
EXC
|
+$6.32M |
| 4 |
Cincinnati Financial
CINF
|
+$6.04M |
| 5 |
Johnson Controls International
JCI
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.54% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Industrials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Weyerhaeuser
WY
$18.2B
| $540K | 0.07% |
+31,887
| New | +$839K |
|
402
Qorvo
QRVO
$8.56B
| $539K | 0.07% |
+6,686
| New | +$669K |
|
|
LADR
403
Ladder Capital
LADR
$1.22B
| $535K | 0.07% |
112,823
+112,804
| +593,705% | +$1.71M |
|
404
Capital One
COF
$134B
| $534K | 0.07% |
+10,585
| New | +$931K |
|
|
GOOS
405
Canada Goose Holdings
GOOS
$849M
| $531K | 0.07% |
26,708
+4,562
| +21% | +$128K |
|
406
Costamare
CMRE
$1.74B
| $526K | 0.07% |
116,400
+116,383
| +684,606% | +$834K |
|
407
D.R. Horton
DHI
$41B
| $526K | 0.07% |
+15,461
| New | +$803K |
|
408
Nordic American Tanker
NAT
$1.33B
| $525K | 0.07% |
+115,912
| New | +$418K |
|
|
SWI
409
DELISTED
SolarWinds Corporation Common Stock
SWI
| $524K | 0.07% |
+31,693
| New | +$586K |
|
410
Resideo Technologies
REZI
$3.67B
| $523K | 0.07% |
108,046
+48,673
| +82% | +$459K |
|
411
Sibanye-Stillwater
SBSW
$7.55B
| $515K | 0.07% |
109,116
+81,376
| +293% | +$727K |
|
412
Descartes Systems
DSGX
$6.86B
| $514K | 0.07% |
+14,937
| New | +$621K |
|
413
Cardinal Health
CAH
$55.5B
| $510K | 0.07% |
10,643
+8,554
| +409% | +$444K |
|
|
GAP
414
The Gap Inc
GAP
$7.74B
| $509K | 0.07% |
+72,291
| New | +$1.07M |
|
|
NVRO
415
DELISTED
NEVRO CORP.
NVRO
| $509K | 0.07% |
5,092
+5,090
| +254,500% | +$612K |
|
416
Emergent Biosolutions
EBS
$229M
| $508K | 0.07% |
8,775
+8,175
| +1,363% | +$471K |
|
417
Cintas
CTAS
$81.1B
| $505K | 0.07% |
+11,664
| New | +$762K |
|
418
Takeda Pharmaceutical
TAK
$56B
| $498K | 0.07% |
32,796
+8,468
| +35% | +$153K |
|
419
WIX.com
WIX
$2.61B
| $498K | 0.07% |
4,942
-1,889
| -28% | -$247K |
|
420
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.21B
| $496K | 0.07% |
24,292
+17,925
| +282% | +$567K |
|
421
FNB Corp
FNB
$6.75B
| $493K | 0.07% |
+66,904
| New | +$706K |
|
|
ETFC
422
DELISTED
E*Trade Financial Corporation
ETFC
| $492K | 0.07% |
14,330
+13,749
| +2,366% | +$581K |
|
423
Brighthouse Financial
BHF
$3.46B
| $488K | 0.06% |
+20,199
| New | +$715K |
|
424
IMAX
IMAX
$2.81B
| $488K | 0.06% |
53,937
+52,646
| +4,078% | +$833K |
|
425
Genuine Parts
GPC
$18.5B
| $487K | 0.06% |
+7,226
| New | +$643K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q1 2020 Portfolio in Review
As of Q1 2020, Aigen Investment Management held 1,737 positions worth $753M, up 25% from $604M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Aigen Investment Management deployed $464M of net new capital in Q1 2020, opening 568 new positions and adding to 434 existing holdings. Its largest new stake was Nucor: 215,804 shares worth $7.77M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $10M trimmed.
- Aigen Investment Management's largest Q1 2020 buy was Nucor: 215,804 shares worth $7.77M.
- Aigen Investment Management added most to Thermo Fisher Scientific in Q1 2020, an estimated $11.5M increase.
- Aigen Investment Management's biggest Q1 2020 reduction was Zoetis, cutting an estimated $10M.
- Aigen Investment Management fully exited FirstEnergy in Q1 2020, selling an estimated $7.33M.
- Aigen Investment Management's ten largest holdings make up 9.4% of its $753M portfolio in Q1 2020.
- Aigen Investment Management opened 568 new positions and closed 491 in Q1 2020.
- Aigen Investment Management's portfolio value rose 25% quarter-over-quarter to $753M.
Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.